Pleural Fluid Cytokine Levels at Baseline and Over Time are Associated With Time to IPC Removal-Reference-Cited by-同舟云学术

Pleural Fluid Cytokine Levels at Baseline and Over Time are Associated With Time to IPC Removal

Published:2020-01 Issue:1 Volume:27 Page:4-13
ISSN:1944-6586
Container-title:Journal of Bronchology & Interventional Pulmonology
language:en
Short-container-title:

Author:

Grosu Horiana B.,Lu Wei,Ost David E.,Vial Macarena R.,Hernandez Mike,Ghosh Natasha,Noor Laila,Hasan Arain M.,Bashoura Lara,Faiz Saadia,Balachandran Dave,Casal Roberto,Eapen George,Shannon Vickie,Sheshadri Ajay,Tang Ximing,Rahman Najib,Wistuba Ignacio I.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pulmonary and Respiratory Medicine

Reference30 articles.

1. Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters;Musani;Respiration,2004

2. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions;Putnam;Cancer,1999

3. Advanced medical interventions in pleural disease;Bhatnagar;European Respir Rev,2016

4. Inhibition of mammalian target of rapamycin augments lipopolysaccharide-induced lung injury and apoptosis;Fielhaber;J Immunol,2012

5. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion;Tremblay;Chest,2006

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malignant pleural effusion: Updates in diagnosis, management and current challenges;Frontiers in Oncology;2022-11-17

2. Inflammation of the Pleural Cavity: A Review on Pathogenesis, Diagnosis and Implications in Tumor Pathophysiology;Cancers;2022-03-10

3. Systemic Inflammatory Response to Different Sclerosing Agents as a Predictor of Pleurodesis Outcome;In Vivo;2021

4. Pleurodesis and systemic inflammatory markers: Lessons and insights;Respirology;2020-01-16